SCHEMBL3319641

SCHEMBL3319641

[SeH]C1Nc2ccccc2N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 5/20 0.39
BRPF1 P55201 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
GAA P10253 2/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
ALOX15 P16050 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
GFER P55789 1/20 0.38
TNKS2 Q9H2K2 3/20 0.37
IDO1 P14902 1/20 0.36
BRD4 O60885 4/20 0.35
EP300 Q09472 1/20 0.35
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 1/20 0.32
KDM4E B2RXH2 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NOS2 P35228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17376745 0.73 CREBBP (0.42) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL13834469 0.71 KMT2A (0.68) KMT2AMEN1GAAMAPTNPC1
SCHEMBL12841651 0.69 CREBBP (0.39) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL13949315 0.69 MAPT (0.43) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL9718691 0.69 CREBBP (0.39) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL8279432 0.69 CREBBP (0.50) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL4265282 0.69 CREBBP (0.39) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL6587899 0.69 CREBBP (0.50) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL5458130 0.69 IDO1 (0.46) CREBBPBRPF1KMT2AMEN1GAA
SCHEMBL30570964 0.69 CREBBP (0.50) CREBBPBRPF1KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7858105-B2 Inhibitors of melanocyte tyrosinase as topical skin lighteners MEDIQUEST THERAPEUTICS, INC. (US) 2010-12-28 US disclosed
EP-1857109-B1 Inhibitors of melanocyte tyrosinase as topical skin lighteners MEDIQUEST THERAPEUTICS INC (US) 2010-09-22 EP disclosed
US-7718185-B2 Inhibitors of melanocyte tyrosinase as topical skin lighteners MEDIQUEST THERAPEUTICS, INC. (US) 2010-05-18 US disclosed
US-20090023792-A1 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS MEDIQUEST THERAPEUTICS, INC. (US) 2009-01-22 US disclosed
US-20090023793-A1 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS MEDIQUEST THERAPEUTICS, INC. (US) 2009-01-22 US disclosed
EP-1857109-A2 Inhibitors of melanocyte tyrosinase as tropical skin lighteners MediQuest Therapeutics, Inc. (US) 2007-11-21 EP disclosed
EP-1267868-B1 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS MEDIQUEST THERAPEUTICS INC (US) 2007-07-18 EP disclosed
US-20050152859-A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners MEDIQUEST THERAPEUTICS, INC. (US) 2005-07-14 US disclosed
US-20030219393-A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners INTEGRIDERM, INC. 2003-11-27 US disclosed
EP-1267868-A2 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS Integriderm, Inc. (US) 2003-01-02 EP disclosed
US-20020044914-A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners INTEGRIDERM, INC. 2002-04-18 US disclosed
WO-2001064206-A2 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS INTEGRIDERM, INC. (US) 2001-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050152859-A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners TYR, MC1R, MITF CREBBP 1269/4885BRPF1 3071/4885KMT2A 1086/4885
US-20030219393-A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners TYR, MC1R, MITF CREBBP 1269/4885BRPF1 3071/4885KMT2A 1086/4885
US-20090023792-A1 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS TYR, MC1R, MITF CREBBP 1269/4885BRPF1 3071/4885KMT2A 1086/4885
US-20020044914-A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners TYR, MC1R, MITF CREBBP 1269/4885BRPF1 3071/4885KMT2A 1086/4885
US-20090023793-A1 INHIBITORS OF MELANOCYTE TYROSINASE AS TOPICAL SKIN LIGHTENERS TYR, MC1R, MITF CREBBP 1269/4885BRPF1 3071/4885KMT2A 1086/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.